Insider Transactions in Q2 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-1.22%
|
$512,690
$167.29 P/Share
|
|
Jun 16
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-0.98%
|
$489,000
$163.98 P/Share
|
|
Jun 13
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
5,000
-14.29%
|
$825,000
$165.85 P/Share
|
|
Jun 10
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,000
-22.28%
|
$656,000
$164.68 P/Share
|
|
Jun 02
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,111
-1.11%
|
$959,427
$157.14 P/Share
|
|
Jun 02
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$471,000
$157.75 P/Share
|
|
May 28
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-22.22%
|
$1,610,000
$161.0 P/Share
|
|
May 20
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-18.18%
|
$1,530,000
$153.9 P/Share
|
|
May 16
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
19,000
-13.79%
|
$2,888,000
$152.85 P/Share
|
|
May 15
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-11.9%
|
$1,500,000
$150.2 P/Share
|
|
May 12
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.08%
|
$474,000
$158.24 P/Share
|
|
May 09
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.17%
|
$488,130
$159.52 P/Share
|
|
May 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,000
-4.72%
|
$596,000
$149.99 P/Share
|
|
May 01
2025
|
Gail Boxer Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+22.59%
|
$96,000
$24.42 P/Share
|
|
May 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.54%
|
$450,000
$150.4 P/Share
|
|
May 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,980
-0.92%
|
$1,047,000
$150.37 P/Share
|
|
Apr 29
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,045
-1.05%
|
$468,930
$154.26 P/Share
|
|
Apr 28
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,018
-2.67%
|
$306,736
$152.18 P/Share
|
|
Apr 28
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,203
-3.13%
|
$942,856
$152.18 P/Share
|
|
Apr 28
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
1,709
-1.09%
|
$259,768
$152.18 P/Share
|
|
Apr 28
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
75
-0.05%
|
-
|
|
Apr 28
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
2,206
-1.56%
|
$335,312
$152.18 P/Share
|
|
Apr 28
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,993
-0.88%
|
$302,936
$152.18 P/Share
|
|
Apr 28
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
1,718
-0.07%
|
$261,136
$152.18 P/Share
|
|
Apr 28
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
439
-0.17%
|
$66,728
$152.18 P/Share
|
|
Apr 25
2025
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
116
+0.72%
|
-
|
|
Apr 25
2025
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
185
+4.31%
|
-
|
|
Apr 25
2025
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
142
+0.31%
|
-
|
|
Apr 25
2025
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
164
+0.25%
|
-
|
|
Apr 24
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
755
-0.5%
|
$114,760
$152.46 P/Share
|
|
Apr 23
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
495
-0.64%
|
$74,250
$150.74 P/Share
|
|
Apr 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.6%
|
-
|
|
Apr 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
911
-0.6%
|
$131,184
$144.83 P/Share
|
|
Apr 21
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
86
-0.02%
|
$12,470
$145.85 P/Share
|
|
Apr 21
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
470
-0.1%
|
$68,150
$145.85 P/Share
|
|
Apr 21
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
296
-0.1%
|
$43,216
$146.2 P/Share
|
|
Apr 21
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
343
-0.11%
|
$49,735
$145.82 P/Share
|
|
Apr 21
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,664
-0.42%
|
$241,280
$145.81 P/Share
|
|
Apr 21
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
610
-0.4%
|
$88,450
$145.85 P/Share
|
|
Apr 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.07%
|
-
|
|
Apr 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.38%
|
-
|
|
Apr 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.66%
|
-
|
|
Apr 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,521
+1.94%
|
-
|
|
Apr 04
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.24%
|
$411,380
$134.09 P/Share
|
|
Apr 03
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-0.81%
|
$417,000
$139.28 P/Share
|
|
Apr 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.7%
|
$420,000
$140.79 P/Share
|
|
Apr 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,000
-6.55%
|
$564,000
$141.14 P/Share
|
|
Apr 01
2025
|
Gail Boxer Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+13.38%
|
$64,000
$16.14 P/Share
|
|
Apr 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
15,898
-1.92%
|
$2,225,720
$140.74 P/Share
|